About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Universal Therapeutic Target for Treatment of Deadly Diseases

by Himabindu Venkatakrishnan on December 30, 2014 at 10:28 PM
 Universal Therapeutic Target for Treatment of Deadly Diseases

Deadly diseases like brain cancer, Ebola, influenza, hepatitis, etc could be treated by targeting a protein called GRP78, a potential universal therapeutic target, says a new study. The superbug bacteria such as MRSE and MRSA could also be treated with this therapeutic agent.

By using a drug combination of the clinically tested OSU-03012 (AR-12) and FDA approved Phosphodiesterase 5 Inhibitors (Viagra, Cialis) to target GRP78 and related proteins, researchers prevented the replication of a variety of major viruses in infected cells, made antibiotic-resistant bacteria vulnerable to common antibiotics and found evidence that brain cancer stem cells were killed.

Advertisement

Data were obtained in multiple brain cancer stem cell types, and using Influenza, Mumps, Measles, Rubella, RSV, CMV, Adenovirus, Coxsakie virus, Chikungunya, Ebola, Hepatitis, E. coli, MRSA, MRSE and N. gonorrhoeae, among others.

The chaperone proteins are very important in cancer cells or virus infected cells because these cells make extra protein compared to normal / uninfected cells.
Advertisement

The team found that the OSU/Viagra drug combination reduced infectivity via reduced viral receptor expression on the surface of target cells and the prevention of virus replication in infected cells.

The drug combination was able to reduce expression of viral receptors for Ebola, Marburg, Hepatitis A, B and C, and Lassa fever viruses. In cancer cells the drug combination reduced the expression of oncogene receptors, too.

In bacteria, the drug combination reduced expression of the equivalent GRP78 protein, in bacteria called Dna K, and induced cell death in pan-antibiotic resistant forms of E. coli, MRSE, MRSA and N. gonorrhoeae.

The study is published in the Journal of Cellular Physiology.

Source: ANI
Font : A-A+

Advertisement

Advertisement
Advertisement

Latest Research News

Connecting Genetic Variants to the Alzheimer's Puzzle
Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.
Gene Therapy Sparks Spinal Cord Regeneration
Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.
Unlocking the Gut Microbiome's Influence on Bone Density
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
Hop-Derived Compound Reduces Gut Microbe Linked to Metabolic Syndrome
Consuming a diet rich in saturated fats triggers persistent, low-level inflammation within the body, ultimately contributing to the onset of metabolic syndrome.
Breakthrough in Mosquitoes for Fighting Dengue Fever
Ae. aegypti mosquitoes are carriers of "arthropod-borne" or "arbo-" viruses, which encompass the dengue virus, yellow fever virus, Zika virus, and chikungunya virus.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Universal Therapeutic Target for Treatment of Deadly Diseases Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests